隨著疫情防控措施(shi)的逐步優(you)化，市場對預(yu)防新冠病毒的藥(yao)(yao)(yao)物關(guan)注度(du)與日(ri)俱增。除(chu)連花清瘟(wen)、布洛芬等熱點藥(yao)(yao)(yao)物之外(wai)，熊去(qu)氧(yang)(yang)(yang)(yang)膽酸也進入了人們(men)視線。12月7日(ri)，熊去(qu)氧(yang)(yang)(yang)(yang)膽酸板塊大漲，共同藥(yao)(yao)(yao)業、海(hai)辰藥(yao)(yao)(yao)業等多只概念股(gu)漲停，賽升藥(yao)(yao)(yao)業、華潤雙(shuang)鶴(he)等跟漲。12月7日(ri)，投資者(zhe)互動(dong)平臺上(shang)關(guan)于熊去(qu)氧(yang)(yang)(yang)(yang)膽酸的關(guan)注度(du)驟升，多家上(shang)市公(gong)(gong)司(si)被提問熊去(qu)氧(yang)(yang)(yang)(yang)膽酸相(xiang)關(guan)業務。新華制(zhi)藥(yao)(yao)(yao)在(zai)互動(dong)平臺上(shang)回(hui)復稱(cheng)公(gong)(gong)司(si)全資子公(gong)(gong)司(si)新達制(zhi)藥(yao)(yao)(yao)已經取得治療膽固醇型膽結石藥(yao)(yao)(yao)物熊去(qu)氧(yang)(yang)(yang)(yang)膽酸片上(shang)市許可持(chi)有(you)人資格(ge)。華潤雙(shuang)鶴(he)相(xiang)關(guan)負(fu)責人在(zai)接(jie)受記者(zhe)采訪時表示，公(gong)(gong)司(si)擁有(you)熊去(qu)氧(yang)(yang)(yang)(yang)膽酸批文，但目前還未生產(chan)。（證券日(ri)報）